The jury in Martin Shkreli’s securities fraud case has found the former pharmaceutical executive guilty on three counts related to a scheme in which he allegedly defrauded investors in two hedge funds and paid them back by pilfering another company he formed.

The jury of seven women and five men found him guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud.